Concepedia
Statistics
Publications
30
Citations
11.8K
H-Index
27
Active since
1986
Affiliations
Novartis (United States)(Current)
Penn State Milton S. Hershey Medical Center
Novartis (Switzerland)
The University of Texas MD Anderson Cancer Center
University of California, Los Angeles
John J. Seaman is an author at Novartis (United States) specializing in medicine, oncology, and osteoporosis.
Top concepts
MedicineOncologyOsteoporosisPharmacologyCancer ResearchRadiation OncologyUrologyBone HealthCancer TherapyHealth
Publications per year
1986–2018
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
James R. Berenson, Alan Lichtenstein, Lester Porter et al. · New England Journal of Medicine · 1996 · 1.1K citations
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
Gabriel N. Hortobágyi, Richard L. Theriault, Lester Porter et al. · New England Journal of Medicine · 1996 · 1K citations
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
Lee S. Rosen, David Gordon, Mary Kaminski et al. · PubMed · 2002 · 899 citations
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma
Lee S. Rosen, David Gordon, Mary Kaminski et al. · Cancer · 2003 · 872 citations · Full text
Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials
Pierre Major, Alain Lortholary, Jeremy K. Hon et al. · Journal of Clinical Oncology · 2001 · 851 citations
1–5 of 30